An older couple holds hands in an autumn park.

Treatment

What treatments exist?

An overview of the main treatments for non-small cell lung cancer (NSCLC), and how the test result shapes the choice.

  • 8 min read
  • Updated 17 November 2026

Most important in brief

  • The building blocks are surgery and radiotherapy, chemotherapy, immunotherapy, targeted tablets and antibodies. They are often combined.
  • At an early stage there are often three steps: before surgery, the main treatment and afterwards.
  • In stage IV, treatment goes line by line. The test result helps decide whether a tablet or immunotherapy comes first.
  • Which chemotherapy fits also depends on the form, adenocarcinoma or squamous cell carcinoma.

This page explains non-small cell lung cancer (NSCLC). Small cell lung cancer is tested and treated differently. Everything about it on its own page →

The main types of treatment

Which treatment is suitable depends on the stage, your general health and the features of the tumour. Often several treatments are combined.

TreatmentWhat happensWhen it may be used
Surgery
The tumour is removed, usually with one lobe of the lung.
Mainly in stages I to IIIA, when it can be removed completely.
Radiotherapy
Targeted radiation: very precise in a few sessions (SBRT), together with chemo, or to ease symptoms.
At any stage, with different aims.
Chemotherapy
Medicines attack dividing cells. Usually two together, one of them containing platinum.
At any stage, often together with immunotherapy or radiotherapy.
Immunotherapy
Releases a brake on the immune system so it recognises the cancer.
Without a matching tablet often as the first treatment; also before or after surgery. The PD-L1 level helps choose.
Targeted tablet
Blocks a specific change in the tumour.
When a matching change has been found; depending on the change as the first or a later treatment, with EGFR and ALK also after surgery.
Antibody
Proteins that attach to cancer cells or blood vessels. Some bring in immune cells (bispecific), some carry a chemo drug directly to the cell (antibody-drug conjugate).
Depending on the test result and line, usually together with other medicines.
Supportive care
Eases pain, breathlessness, nausea and other symptoms.
Always, from the start.

The colours are the same as in My path. There, every building block opens a profile.

Early stage: before, main treatment, afterwards

In stages I to III the aim is usually cure. Treatment then often has three steps. The tumour board decides which of them fit you.

StepOptionWhen
Before surgery
Chemotherapy with immunotherapye.g.++or++or++
Often for stage II–III when surgery is possible. The chemo depends on the tissue type: for adenocarcinoma usually with pemetrexed, for squamous cell carcinoma with paclitaxel or gemcitabine. Nivolumab only with PD-L1 of 1% or more.
Main treatment
When the tumour can be removed completely.
For a small tumour, when surgery is not possible.
e.g.++or++or++
For stage III, when surgery is not possible. Chemo and radiotherapy at the same time; pemetrexed only for adenocarcinoma.
Afterwards
Immunotherapy after chemoradiotherapye.g.
For stage III, PD-L1 of 1% or more, for up to 12 months.
Immunotherapy after surgerye.g.
After platinum chemotherapy, with a high risk of return, at any PD-L1 level.
Immunotherapy after surgery, with high PD-L1e.g.
After platinum chemotherapy, only with PD-L1 of 50% or more.
Continue immunotherapye.g.oror
If it was already given with chemotherapy before surgery.
Chemotherapye.g.+or+
After surgery for some stages, to lower the risk of return. Pemetrexed only for adenocarcinoma; carboplatin instead of cisplatin is possible.
If it comes back
Treatment as in stage IV
If the cancer comes back elsewhere, it is usually treated line by line with medicines, as in stage IV. A new test is often done then.
Local treatment again
If it comes back in just one place, surgery or radiotherapy is sometimes possible again, aimed at cure.
Alongside
Supportive care
For symptoms, from the start.
Rehabilitation, breathing exercises and stopping smoking
Help recovery and lower the risk of complications.

With EGFR or ALK, a tablet after surgery is an option instead of immunotherapy (EGFR, ALK and ROS1). Simplified, examples without ranking.

First and later treatment

In stage IV, doctors talk about “lines” of treatment. First-line is the first treatment that works throughout the body. If the cancer grows again later, or the treatment is not tolerated, a second-line treatment follows.

Which treatment fits in which line also depends on the test results. This is how the professional guidelines from ESMO and Onkopedia describe it.

Clear explanations written for patients are in the ESMO patient guide on NSCLC and the NCCN guidelines for patients (the NCCN site may ask you to register).

Chemotherapy: which, when, with what

Chemotherapy for lung cancer usually combines two medicines, one of them containing platinum: carboplatin or cisplatin. The partner depends on the form. Pemetrexed only fits adenocarcinoma; paclitaxel or gemcitabine fit squamous cell carcinoma. Immunotherapy is often added.

SituationChemotherapyGood to know
First treatment in stage IV
Immunotherapy with chemo, for adenocarcinomae.g.++or++or+++or+++
At any PD-L1 level. Cisplatin instead of carboplatin is possible. With nivolumab + ipilimumab only two chemo cycles.
Immunotherapy with chemo, for squamous cell carcinomae.g.++or++or+++
At any PD-L1 level. With nivolumab + ipilimumab only two chemo cycles.
When immunotherapy is not suitable
Chemo alone, for adenocarcinomae.g.+
When immunotherapy is not suitable. Cisplatin instead of carboplatin is possible.
Chemo alone, for squamous cell carcinomae.g.+or+
When immunotherapy is not suitable.
Early stage
Chemotherapy with immunotherapye.g.++or++or++
Often for stage II–III when surgery is possible. The chemo depends on the tissue type: for adenocarcinoma usually with pemetrexed, for squamous cell carcinoma with paclitaxel or gemcitabine. Nivolumab only with PD-L1 of 1% or more.
Chemotherapye.g.+or+
After surgery for some stages, to lower the risk of return. Pemetrexed only for adenocarcinoma; carboplatin instead of cisplatin is possible.
Chemoradiotherapye.g.++or++or++
For stage III, when surgery is not possible. Chemo and radiotherapy at the same time; pemetrexed only for adenocarcinoma.
After a tablet
Platinum chemoe.g.+
When the tablet stops working.
Later line
Chemo alonee.g.
When the first treatment stops working.
Chemo with an antibodye.g.+
When the first treatment stops working.
Chemo with a tablet, for adenocarcinomae.g.+
Nintedanib only for adenocarcinoma.

Simplified, examples without ranking.

How chemotherapy works in practice

Where
In the day clinic, as an infusion
How long
Usually 4 to 6 cycles, about 3 to 4 months
Check-ups
Blood count, kidney and liver values before each cycle
What to watch for
Take a fever over 38 °C seriously and report it at once. Avoid crowds and sick people when blood counts are low. Discuss vaccinations beforehand.

What helps with nausea, tiredness or hair loss is under Living with it.

Targeted medicines depending on your test result

Whether a targeted medicine is suitable depends on the biomarker test results. For some changes, for example EGFR, ALK or ROS1, it is often the very first treatment.

For others, for example KRAS G12C, it is usually a later treatment in the EU (ESMO; Onkopedia).

ChangeFirst treatmentLater
EGFR
Targeted tablet, alone or combined.e.g.or+
Antibody with chemotherapy, chemotherapy, or a trial.e.g.++
ALK
ALK tablet.e.g.oror
Another ALK tablet depending on a new test, or chemotherapy.e.g.
ROS1
ROS1 tablet.e.g.oror
Another ROS1 tablet, or chemotherapy.e.g.
KRAS G12C
Usually immunotherapy, often with chemotherapy.
KRAS G12C tablet, after a first treatment.e.g.or
BRAF V600E
Two tablets together (BRAF and MEK inhibitors).e.g.+or+
Immunotherapy or chemotherapy, if not given yet.
MET exon 14
Usually immunotherapy, often with chemotherapy.
MET tablet, after immunotherapy or platinum chemotherapy.e.g.or
RET
RET tablet.e.g.
Immunotherapy or chemotherapy, if not given yet.
NTRK
Usually the standard treatment first.
NTRK tablet, when other treatments are not suitable.e.g.or
HER2
Usually immunotherapy, often with chemotherapy.
Antibody-drug conjugate by infusion, after platinum chemotherapy.e.g.
Other KRAS forms
Usually immunotherapy, often with chemotherapy.
Chemotherapy. New medicines against these forms are being tested in trials.

Simplified, as of November 2026, examples without ranking. More on each change via the links in the table, and on testing under Tests.

Questions to ask about treatment

  • Why ask?

    Cure, long-term control or relief: the aim decides how much burden makes sense.

  • Why ask?

    There is often more than one way; the reasoning helps you take part in the decision.

  • Why ask?

    Some changes matter straight away, others only for the next treatment.

  • Why ask?

    Every treatment has its own side effects; knowing them lets you act early.

  • Why ask?

    Availability and coverage differ from country to country.

Sources

  1. ESMO Living Guideline: oncogene-addicted metastatic NSCLC
  2. Onkopedia: Lungenkarzinom, nicht-kleinzellig (NSCLC)
  3. ESMO Patient Guide: Non-small cell lung cancer
  4. NCCN Guidelines for Patients
  5. EMA: EPAR sotorasib
  6. EMA: EPAR adagrasib

All sources last checked on 12 November 2026, unless another date is given.